Fourteen quassinoids, obtained from simaroubaceous plants, were tested for in vitro antimalarial activity. All of these inhibited the incorporation of [3H]hypoxanthine into Plasmodium falciparum in vitro at concentrations below 0.41 ,Ig ml-'. The two most potent quassinoids, bruceantin and simalikalactone D, showed 50% inhibitory concentration values of 0.0008 and 0.0009 ,ug ml-1, respectively. The results are compared with the antiamoebic, antileukemic, and cytotoxic activities of these compounds reported in the literature.
In the 1960s, the appearance in Southeast Asia and South America of strains of Plasmodium falciparum showing resistance to chloroquine heralded the need for alternative antiplasmodial therapy. Several hundreds of millions of people suffer from malaria, and all currently used antimalarial drugs now show limitations in their spectra of activity (17) . Resistance of P. falciparum to available antimalarial drugs is an increasing world problem (10) . Therefore, it is crucial that mechanistically novel antimalarial agents be added to our chemotherapeutic armamentarium as soon as possible.
Certain quassinoids, obtained from simaroubaceous plants, are known to possess a variety of biological activities, including antitumor (13) , antiviral (11) , antifeedant (12) , antiamoebic (5) , and antiinflammatory (7) activities. More recently, some of these compounds, namely, bruceantin (6) , simalikalactone D (16), glaucarubinone (16) , soularubinone (16) , and sergeolide (4) , have been found to show high activity against P. falciparum in vitro. Sergeolide also markedly reduces virulence of experimentally induced P. berghei in mice (4); however, it unfortunately also shows high toxicity. In our present study, we monitored the in vitro anti-P. falciparum activities of a series of 14 quassinoids which were made available from isolations performed under the auspices of the National Cancer Institute, Bethesda, Md. Our results are considered in the light of published data for other biological activities of these quassinoids.
(This report is part 2 of a study on plants as sources of antimalarial drugs. For part 1, see reference 9.) (This work was presented in part at the 122nd Annual British Pharmaceutical Conference, Leeds, United Kingdom, 1985.) MATERIALS AND METHODS P. falciparum strain. A chloroquine-resistant strain (K-1) of P. falciparum, which was originally obtained from Thailand (14) and has been cryopreserved at the London School of Hygiene and Tropical Medicine, was used throughout.
Maintenance of cultures. Cultures of P. falciparum were maintained in vitro in human blood cells (O+ve) diluted to * Corresponding author. 5% hematocrit with RPMI 1640 medium (10% human 0 + serum) by published techniques (2, 3, 15 Harvesting. Erythrocytes were washed from the wells with normal saline with a Titertek cell harvester (Flow Laboratories, Inc., McLean, Va.) through a glass fiber membrane predampened with saline. The glass fiber membrane was flushed with distilled water for 20 s to lyse erythrocytes and then flushed with saline for 20 s to remove remaining traces of hemoglobin. After being washed further with distilled water and saline (20 s with each), the membrane was dried, and the glass fiber disc for each well was pushed out into polypropylene scintillation vials (4-ml volume). To each vial, 4 ml of scintillation fluid (Packard toluene scintillator) was added, and the counts per minute were determined for 10 min at about 30% efficiency.
Analysis of results. Counts per minute were converted to disintegrations per minute by using an external standard, and the percentage of inhibition was calculated from the follow- Sources of quassinoids. The compounds used in the study were isolated from species of the family Simaroubaceae and were obtained from the repository of the National Cancer Institute, Bethesda, Md. (Fig. 1, compounds 1 to 14) .
RESULTS
The results are presented in Table 1 . Of the 14 quassinoids tested, all showed in vitro antimalarial activity, having IC50 values below 0.41 ,ug ml-'. Of these quassinoids, 10, from ailanthinone to simalikalactone D (Table 1) , possessed IC50 values of less than 0.02 ,ug ml-'. Chloroquine diphosphate showed an IC50 value of 0.21 ,ug ml-' in the same test.
DISCUSSION
The in vitro antimalarial activities in our study for simalikalactone D (IC50, 0.0009 ,ug ml-l) and glaucarubinone (IC50, 0.004 ,ug ml-') are of the same order as those reported by Trager and Polonsky (16) , namely, 0.002 ,ug ml-' for simalikalactone D and 0.006 ,ug ml-' for glaucarubinone.
The results reported in Table 1 show the importance for activity of the presence of an ester function at C-15; glaucarubin is about three times more active than chaparrin and about eight times more active than glaucarubol. Changes in the nature of this ester function produce marked alterations in activity; glaucarubinone is about twice as potent as holacanthone, whereas bruceantin is more than twice as active as bruceantinol and more than three times as active as brusatol. A comparison of the activities of glaucarubinone and 6a-senecioyloxychaparrinone suggests that an ester function at C-15 improves activity over one at C-6. Also, if the C-15 is already esterified, additional esterification at C-6 appears to offer little enhancement in activity, as shown by the IC50 values of holacanthone and undulatone. The A-ring substitution pattern is apparently crucial to activity; glaucarubinone, having an a,p-unsaturated keto function in ring A, is over 10 times more active than glaucarubin. There is no obvious overall difference in activities of compounds with a C-20 to C-11 oxygen bridge or a C-20 to C-13 oxygen bridge.
The in vitro antimalarial activities of the quassinoids in the present study did not always parallel their other biological activities, as reported in the literature. Table 1 lists reported data for the antileukemic, antiamoebic, and cytotoxic activities of some of the quassinoids tested for in vitro antimalarial activity in this study. Trager and Polonsky (16) reported that the in vitro antimalarial activities of the five quassinoids they tested (viz., simalikalactone D, glaucarubinone, soularubinone, simarolide, and chaparrinone) parallelled their antileukemic activities. In our study, the in vitro antimalarial activities of the quassinoids did not exactly parallel their in vivo murine lymphocyte leukemia (P-388) optimal test-to-control survival values or optimal doses reported by Cassady and Suffness (1) and Suffness (unpublished data). However, the compounds with the highest in vitro antimalarial activity in our test, bruceantin (IC50, 0.0008 ,ug ml-') and simalikalactone D (IC50, 0.0009 ,ug ml-'), rate among the best antileukemic quassinoids reported (Table 1) .
Bruceantin and simalikalactone D were also found (5) to possess the highest in vitro amoebicidal activity of a series of 17 quassinoids examined. Bruceantin had an IC50 of 0.018 ,ug ml-', and simalikalactone D had an IC50 of 0.047 ,ug ml-' in the latter test. Apart from this, there is little similarity between in vitro antimalarial and antiamoebic activities of the quassinoids; glaucarubinone was about twice as active as ailanthinone in the antimalarial test but only half as active as ailanthinone in the antiamoebic test. Also, glaucarubin, which has only relatively modest in vitro antimalarial activity (IC50, 0.055 jxg ml-'), was active in the antiamoebic test (IC50, 1.57 ,ug ml-'), whereas some quassinoids with high in vitro antimalarial activities, viz., holacanthone, undulatone, 6a-senecioyloxychaparrinone, brusatol, bruceantinol, and samaderine E, were not active in the antiamoebic test at 2 ,ug ml-1, the highest concentration tested. It is worth noting that chloroquine sulfate (antiamoebic IC50, 85 ,ug ml-') also displayed little antiamoebic activity.
Some quassinoids are known to be toxic to mammalian cells (1) , and, in the present study, 6a-senecioyloxychaparrinone, bruceantin, and simalikalactone D proved to be the most potent quassinoids tested against 9KB cells (Table 1) . Apart from ailanthinone, 6a-senecioyloxychaparrinone, and simalikalactone D, all of the quassinoids tested were active 
